Glenmark Pharma Sets Aug 31 Record Date for Dividend
Glenmark Pharmaceuticals Ltd announced that its Board of Directors has approved the financial results for the quarter ended June 30, 2026, and set Monday, August 31, 2026, as the record date for determining dividend entitlement. The 48th Annual General Meeting (AGM) will be held on September 11, 2026. The company also approved amendments to several policies including Related Party Transactions, Materiality for Disclosures, Insider Trading, Dividend Distribution, and Nomination and Remuneration. Additionally, the Risk Management Committee has been reconstituted, with Ms. Patricia Andrews appointed as Chairperson, effective August 1, 2026. The company reported unaudited standalone and consolidated financial results for the quarter.
Key Highlights
- Record date for dividend entitlement set as August 31, 2026.
- 48th AGM scheduled for September 11, 2026.
- Board approved unaudited financial results for Q1 FY27.
- Amendments approved for key corporate policies.
- Risk Management Committee reconstituted; new Chairperson appointed.
Price Impact
More from GLENMARK